{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:01:09Z","timestamp":1790949669810,"version":"4.1.0"},"reference-count":65,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Menopause following cancer treatment is an increasingly recognised component of survivorship yet remains under-addressed in clinical care. The aim of this review was to synthesise current evidence on menopause induced by cancer treatment, by bringing together current evidence on the underlying mechanisms, clinical manifestations, and management in the context of survivorship care. Evidence was evaluated from contemporary clinical studies, guideline recommendations, and emerging evidence across oncology and menopause research. Cancer treatment-induced menopause commonly results from surgical removal of the ovaries, follicular depletion from chemotherapy, and radiation-induced ovarian damage, and in some cases, it is chemically induced by gonadotrophin-releasing hormone agonists. The resulting symptom burden is often substantial, including vasomotor symptoms, mood disturbance, genitourinary syndrome, sexual dysfunction, fatigue, and cognitive difficulties that impair quality of life. In addition, premature or early menopause is associated with increased long-term health risks, including reduced bone density, cardiovascular disease, and adverse psychosocial outcomes, such as infertility and altered self-identity. Menopause symptoms can also overlap with treatment side effects, and management is often complex, requiring an individualised, multidisciplinary approach. Whilst hormone replacement therapy is effective, its use is limited by concerns regarding cancer recurrence in hormone-sensitive disease. As a result, non-hormonal and supportive strategies play a pivotal role in symptom management. Despite increasing recognition of the impact of menopause, there are few effective licensed therapies and access to specialist support and counselling is limited. Integrated menopause care that incorporates menopause management into oncology pathways offers a pragmatic approach, providing holistic, patient-centred strategies that balance long-term health risks with quality-of-life priorities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lay summary<\/jats:title>\n                    <jats:p>Cancer treatment, including surgery, chemotherapy, radiotherapy, or long-term therapies, can cause menopause, which is often sudden, resulting in severe symptoms that may overlap with treatment-related side effects. Menopause can therefore be complex to manage, and there may also be added concerns around promoting cancer recurrence. Menopause symptoms can include hot flushes, poor sleep, mood disturbance, vaginal dryness, reduced sexual well-being, fatigue, and problems with memory \u2013 these can all impact daily life. There may also be longer-term health impacts, including bone loss and cardiovascular disease. This review brings together current evidence to discuss why treatment-related menopause occurs and how it can be best managed. It highlights that, despite growing awareness, many cancer survivors do not receive adequate information, support, or treatment for these symptoms. As cancer survival improves, menopause care must become a central part of improved survivorship. Personalised approaches to menopause management have the potential to improve long-term health, well-being, and quality of life after cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/raf-26-0082","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:13:01Z","timestamp":1789564381000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-13","source":"Crossref","is-referenced-by-count":0,"title":["Menopause following cancer treatment-induced menopause: unique considerations and current recommendations"],"prefix":"10.1530","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3865-0888","authenticated-orcid":true,"given":"Gabriella","family":"Yongue","sequence":"first","affiliation":[{"name":"University College London Cancer Institute 1 , ,","place":["London, United Kingdom"]},{"name":"University College London Hospital 2 , ,","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Nash","sequence":"additional","affiliation":[{"name":"University College London Hospital 2 , ,","place":["London, United Kingdom"]},{"name":"EGA Institute for Women\u2019s Health 3 , ,","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyn","family":"Manley","sequence":"additional","affiliation":[{"name":"University Hospitals Bristol NHS Foundation Trust 4 , ,","place":["Bristol, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie C","family":"Davies","sequence":"additional","affiliation":[{"name":"University College London Hospital 2 , ,","place":["London, United Kingdom"]},{"name":"EGA Institute for Women\u2019s Health 3 , ,","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibani","family":"Nicum","sequence":"additional","affiliation":[{"name":"University College London Cancer Institute 1 , ,","place":["London, United Kingdom"]},{"name":"University College London Hospital 2 , ,","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"2026100209393903000_bib1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/13697137.2025.2548806","article-title":"The role of lifestyle medicine in menopausal health: a review of non-pharmacologic interventions","volume":"28","author":"Anekwe","year":"2025","journal-title":"Climacteric"},{"key":"2026100209393903000_bib2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/gme.0b013e31823fe835","article-title":"Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial","volume":"19","author":"Ayers","year":"2012","journal-title":"Menopause"},{"key":"2026100209393903000_bib3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2019-00192","article-title":"Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis","volume":"104","author":"Barrionuevo","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026100209393903000_bib4","first-page":"643","article-title":"Evaluating the efficacy of vaginal for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (alliance)","volume":"26","author":"Barton","year":"2018","journal-title":"Support Care Cancer"},{"key":"2026100209393903000_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/GME.0b013e31826560da","article-title":"Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer","volume":"20","author":"Baumgart","year":"2013","journal-title":"Menopause"},{"key":"2026100209393903000_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.103161","article-title":"Integrating menopause care into oncology: implementation of a multidisciplinary oncology\u2013menopause meeting for gynaecological cancer survivors","volume":"36","author":"Brierley","year":"2026","journal-title":"Int J Gynecol Cancer"},{"key":"2026100209393903000_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10549-015-3511-3","article-title":"Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer","volume":"153","author":"Chien","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2026100209393903000_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1056\/NEJM199101103240205","article-title":"Gonadotropin-releasing hormone and its analogues","volume":"324","author":"Desforges","year":"1991","journal-title":"N Engl J Med"},{"key":"2026100209393903000_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0029665126102201","article-title":"Gut-brain communication in menopause: insights into neuroendocrine and microbiome interactions","author":"Cuozzo","year":"2026","journal-title":"Proc Nutr Soc"},{"key":"2026100209393903000_bib11","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1210\/jc.2009-1523","article-title":"The effect of transdermal testosterone on mammographic density in postmenopausal women not receiving systemic estrogen therapy","volume":"94","author":"Davis","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2026100209393903000_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.maturitas.2018.11.016","article-title":"Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials. Part I: evaluation of efficacy","volume":"121","author":"Di Donato","year":"2019","journal-title":"Maturitas"},{"key":"2026100209393903000_bib13","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(15)60908-4","article-title":"Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials","volume":"386","author":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG)","year":"2015","journal-title":"Lancet"},{"key":"2026100209393903000_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10549-023-07054-3","article-title":"Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC\u2013MS\/MS (liquid chromatography\u2013tandem mass spectrometry) method for estrogen measurement","volume":"201","author":"Faltinov\u00e1","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"2026100209393903000_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jacc.2022.04.042","article-title":"Cardiovascular disease risk among cancer survivors","volume":"80","author":"Florido","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026100209393903000_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"2026100209393903000_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bpobgyn.2020.01.006","article-title":"Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers","volume":"65","author":"Gaba","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2026100209393903000_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2015.2653","article-title":"Association of age at menopause and duration of reproductive period with depression after menopause: a systematic review and meta-analysis","volume":"73","author":"Georgakis","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"2026100209393903000_bib19","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ygyno.2021.10.001","article-title":"Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study","volume":"163","author":"Gernier","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2026100209393903000_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/annonc\/mdl030","article-title":"Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment","volume":"17","author":"Glaus","year":"2006","journal-title":"Ann Oncol"},{"key":"2026100209393903000_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/13697137.2019.1574738","article-title":"The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis","volume":"22","author":"Golezar","year":"2019","journal-title":"Climacteric"},{"key":"2026100209393903000_bib36","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2026.0033","article-title":"Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology","volume":"24","author":"Gradishar","year":"2026","journal-title":"J Natl Compr Canc Netw"},{"key":"2026100209393903000_bib22","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(23)02802-7","article-title":"Managing menopause after cancer","volume":"403","author":"Hickey","year":"2024","journal-title":"Lancet"},{"key":"2026100209393903000_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ygyno.2021.07.029","article-title":"What happens after menopause? (WHAM): a prospective controlled study of vasomotor symptoms and menopause-related quality of life 12 months after premenopausal risk-reducing salpingo-oophorectomy","volume":"163","author":"Hickey","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2026100209393903000_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2025.108670","article-title":"PERCEIVE: a retrospective, qualitative interview-based study of the impact of vasomotor symptoms associated with menopause on the lives of individuals who are not suitable candidates for hormone therapy","volume":"200","author":"Hirschberg","year":"2025","journal-title":"Maturitas"},{"key":"2026100209393903000_bib25","first-page":"2245","article-title":"Does a multidisciplinary menopausal symptoms after cancer clinic reduce symptoms?","volume":"30","author":"Hollingworth","year":"2022","journal-title":"Support Care Cancer"},{"key":"2026100209393903000_bib26","volume-title":"ESTEEM: A Clinical Trial Testing Whether Testosterone Can Help Improve the Quality of Life During Menopause","author":"ISRCTN Registry 2025"},{"key":"2026100209393903000_bib27","first-page":"1033","article-title":"Biology and receptor interactions of estriol and estriol derivatives in vitro and in vivo","volume":"20","author":"Katzenellenbogen","year":"1984","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026100209393903000_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1470-2045(08)70341-3","article-title":"Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial","volume":"10","author":"Kenemans","year":"2009","journal-title":"Lancet Oncol"},{"key":"2026100209393903000_bib29","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1001\/jamaoncol.2021.1160","article-title":"Applying a life course biological age framework to improving the care of individuals with adult cancers: review and research recommendations","volume":"7","author":"Mandelblatt","year":"2021","journal-title":"JAMA Oncol"},{"key":"2026100209393903000_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/GME.0b013e3182976f46","article-title":"Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history","volume":"21","author":"Marino","year":"2014","journal-title":"Menopause"},{"key":"2026100209393903000_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/2053369116668738","article-title":"The menopause specialist and breast cancer survivorship","volume":"22","author":"Marsden","year":"2016","journal-title":"Post Reprod Health"},{"key":"2026100209393903000_bib32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","article-title":"Toxicity of chemotherapy and radiation on female reproduction","volume":"53","author":"Meirow","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"2026100209393903000_bib33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/tog.70010","article-title":"Menopause care: alternatives to hormone replacement therapy","volume":"27","author":"Mullin","year":"2025","journal-title":"Obstet Gynaecol"},{"key":"2026100209393903000_bib34","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3390\/cancers17172726","article-title":"Aromatase inhibitors as adjuvant therapy in early breast cancer: insights into toxicities and their management","volume":"17","author":"Nardin","year":"2025","journal-title":"Cancers"},{"key":"2026100209393903000_bib35","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/S0140-6736(24)02602-3","article-title":"Top ten menopause research priorities","volume":"404","author":"Nash","year":"2024","journal-title":"Lancet"},{"key":"2026100209393903000_bib37","article-title":"Menopause: management \u2013 management of menopause, perimenopause, or premature ovarian insufficiency","volume-title":"NICE Clinical Knowledge Summary","author":"National Institute for Health and Care Excellence 2025"},{"key":"2026100209393903000_bib38","article-title":"DailyMed: SOLTAMOX \u2013 tamoxifen citrate liquid","author":"National Library of Medicine 2021","journal-title":"DailyMed"},{"key":"2026100209393903000_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoae065","article-title":"Evidence-based guideline: premature ovarian insufficiency","volume":"2024","author":"Panay","year":"2024","journal-title":"Hum Reprod Open"},{"key":"2026100209393903000_bib40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/08870446.2017.1320799","article-title":"Experiencing menopause in the context of cancer: women\u2019s constructions of gendered subjectivities","volume":"32","author":"Parton","year":"2017","journal-title":"Psychol Health"},{"key":"2026100209393903000_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-021-06117-7","article-title":"Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors","volume":"187","author":"Peate","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"2026100209393903000_bib42","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1210\/jc.2013-4145","article-title":"Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement","volume":"99","author":"Popat","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026100209393903000_bib43","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1538-7836.2010.03839.x","article-title":"Hormone replacement therapy and the risk of venous thromboembolism: a population-based study","volume":"8","author":"Renoux","year":"2010","journal-title":"J Thromb Haemostasis"},{"key":"2026100209393903000_bib44","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause","volume":"69","author":"Rocca","year":"2007","journal-title":"Neurology"},{"key":"2026100209393903000_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71383","article-title":"Chemobrain and cancer survivorship: a scoping review of the literature","volume":"14","author":"Rovito","year":"2025","journal-title":"Cancer Med"},{"key":"2026100209393903000_bib46","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.3390\/cancers15204923","article-title":"The role of cyclin-dependent kinases (CDK) 4\/6 in the ovarian tissue and the possible effects of their exogenous inhibition","volume":"15","author":"Scavone","year":"2023","journal-title":"Cancers"},{"key":"2026100209393903000_bib47","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/13697137.2011.571320","article-title":"The silent grief: psychosocial aspects of premature ovarian failure","volume":"14","author":"Singer","year":"2011","journal-title":"Climacteric"},{"key":"2026100209393903000_bib48","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/GME.0000000000000451","article-title":"Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women\u2019s Health Initiative Observational Study","volume":"22","author":"Sullivan","year":"2015","journal-title":"Menopause"},{"key":"2026100209393903000_bib49","first-page":"218","author":"Talaulikar","year":"2025"},{"key":"2026100209393903000_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/13697137.2015.1094784","article-title":"Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis","volume":"19","author":"Tao","year":"2016","journal-title":"Climacteric"},{"key":"2026100209393903000_bib51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13058-024-01886-7","article-title":"Safety and efficacy of topical testosterone in breast cancer patients receiving ovarian suppression and aromatase inhibitor therapy","volume":"26","author":"Taranto","year":"2024","journal-title":"Breast Cancer Res"},{"key":"2026100209393903000_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/20533691241286666","volume":"30","author":"Taylor","year":"2024","journal-title":"Post Reprod Health"},{"key":"2026100209393903000_bib52","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41416-021-01392-z","article-title":"Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank","volume":"125","author":"Tin Tin","year":"2021","journal-title":"Br J Cancer"},{"key":"2026100209393903000_bib53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/GME.0000000000002367","article-title":"Association of muscle disorders in late postmenopausal women according to the type of experienced menopause","volume":"31","author":"Vallejo","year":"2024","journal-title":"Menopause"},{"key":"2026100209393903000_bib54","doi-asserted-by":"crossref","first-page":"k4810","DOI":"10.1136\/bmj.k4810","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova","year":"2019","journal-title":"BMJ"},{"key":"2026100209393903000_bib55","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1002\/cncr.28849","article-title":"Complications of pelvic radiation in patients treated for gynecologic malignancies","volume":"120","author":"Viswanathan","year":"2014","journal-title":"Cancer"},{"key":"2026100209393903000_bib56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1470-2045(05)70092-9","article-title":"Fertility preservation for young patients with cancer: who is at risk and what can be offered?","volume":"6","author":"Wallace","year":"2005","journal-title":"Lancet Oncol"},{"key":"2026100209393903000_bib57","article-title":"Changes of hormone levels for postmenopausal women after bilateral oophorectomy: a meta-analysis","volume":"104","author":"Wu","year":"2025","journal-title":"Medicine"},{"key":"2026100209393903000_bib58","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jamaoncol.2024.4318","article-title":"Fracture risk prediction using the fracture risk assessment tool in individuals with cancer","volume":"10","author":"Ye","year":"2024","journal-title":"JAMA Oncol"},{"key":"2026100209393903000_bib59","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/GME.0000000000001972","article-title":"Positive impact of a co-designed digital resource for women with early menopause","volume":"29","author":"Yeganeh","year":"2022","journal-title":"Menopause"},{"key":"2026100209393903000_bib60","first-page":"A357.1\u2013A357","article-title":"#490 National Cancer Research Institute (NCRI) survey of hormone replacement therapy prescribing in gynaecological and breast cancer survivors and in women who have had risk-reducing oophorectomy in the United Kingdom","volume-title":"Poster\/ePoster Sessions. Presented at the ESGO 2023 Congress","author":"Yongue","year":"2023"},{"key":"2026100209393903000_bib61","first-page":"In press","article-title":"Risk of cancer with hormone replacement therapy: a narrative review","author":"Yongue","year":"2026","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"2026100209393903000_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17121987","article-title":"Vitamin D concentration among women with gynecological cancers","volume":"17","author":"Z\u0119balski","year":"2025","journal-title":"Cancers"},{"key":"2026100209393903000_bib63","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ejendo\/lvaf102","article-title":"Association between premature ovarian insufficiency and biological aging","volume":"192","author":"Zhou","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"2026100209393903000_bib65","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2468-2667(19)30155-0","article-title":"Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data","volume":"4","author":"Zhu","year":"2019","journal-title":"Lancet Public Health"},{"key":"2026100209393903000_bib64","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/humrep\/deaa124","article-title":"Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies","volume":"35","author":"Zhu","year":"2020","journal-title":"Hum Reprod"}],"container-title":["Reproduction and Fertility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/raf\/article-pdf\/doi\/10.1530\/RAF-26-0082\/525393\/raf-26-0082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/raf\/article-pdf\/doi\/10.1530\/RAF-26-0082\/525393\/raf-26-0082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:39:49Z","timestamp":1790948389000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/raf\/article\/7\/4\/RAF260082\/78221\/Menopause-following-cancer-treatment-induced"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1530\/raf-26-0082","relation":{},"ISSN":["2633-8386"],"issn-type":[{"value":"2633-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"RAF260082"}}